Zobrazeno 1 - 10
of 227
pro vyhledávání: '"John P, Cheatham"'
Autor:
Kevin M. Flanigan, Tatyana A. Vetter, Tabatha R. Simmons, Megan Iammarino, Emma C. Frair, Federica Rinaldi, Louis G. Chicoine, Johan Harris, John P. Cheatham, Sharon L. Cheatham, Brian Boe, Megan A. Waldrop, Deborah A. Zygmunt, Davin Packer, Paul T. Martin
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 27, Iss , Pp 47-60 (2022)
In a phase 1/2, open-label dose escalation trial, we delivered rAAVrh74.MCK.GALGT2 (also B4GALNT2) bilaterally to the legs of two boys with Duchenne muscular dystrophy using intravascular limb infusion. Subject 1 (age 8.9 years at dosing) received 2.
Externí odkaz:
https://doaj.org/article/5d4cb4d3fc0f4849bd3ccf973f1e61e1
Autor:
Rui Xu, Ying Jia, Deborah A. Zygmunt, Megan L. Cramer, Kelly E. Crowe, Guohong Shao, Agatha E. Maki, Haley N. Guggenheim, Benjamin C. Hood, Danielle A. Griffin, Ellyn Peterson, Brad Bolon, John P. Cheatham, Sharon L. Cheatham, Kevin M. Flanigan, Louise R. Rodino-Klapac, Louis G. Chicoine, Paul T. Martin
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 10, Iss , Pp 89-104 (2018)
Recombinant adeno-associated virus (rAAV)rh74.MCK.GALGT2 is a muscle-specific gene therapy that is being developed to treat forms of muscular dystrophy. Here we report on an isolated limb infusion technique in a non-human primate model, where hindlim
Externí odkaz:
https://doaj.org/article/f9bc6cfb8158407cb2dff2b604340149
Autor:
Matthew J. Gillespie, Doff B. McElhinney, Thomas K. Jones, Daniel S. Levi, Jeremy Asnes, Robert G. Gray, Allison K. Cabalka, Kazuto Fujimoto, Athar M. Qureshi, Henri Justino, Lisa Bergersen, Lee N. Benson, Daniel Haugan, Brian A. Boe, John P. Cheatham
Publikováno v:
JACC: Cardiovascular Interventions.
Autor:
Yuichi Matsuzaki, Darren P. Berman, Hirotsugu Kurobe, John M. Kelly, Ryuma Iwaki, Kevin Blum, Shoji Toshihiro, Andrew Harrison, John P. Cheatham, Toshiharu Shinoka
Publikováno v:
Pediatric Cardiology. 43:986-994
To date, there has been limited investigation of bioabsorbable atrial septal defect (ASD) or patent foramen ovale (PFO) closure devices using clinically relevant large animal models. The purpose of this study is to explore the function and safety of
Autor:
Doff B, McElhinney, Yulin, Zhang, Daniel S, Levi, Stanimir, Georgiev, Elżbieta Katarzyna, Biernacka, Bryan H, Goldstein, Shabana, Shahanavaz, Athar M, Qureshi, Allison K, Cabalka, Holly, Bauser-Heaton, Alejandro J, Torres, Brian H, Morray, Aimee K, Armstrong, Oscar, Millan-Iturbe, Lynn F, Peng, Jamil A, Aboulhosn, Witold, Rużyłło, Felix, Berger, Lars, Sondergaard, Dietmar, Schranz, John P, Cheatham, Thomas K, Jones, Peter, Ewert, Stephan, Schubert
Publikováno v:
Journal of the American College of Cardiology. 79:18-32
Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a prosthetic conduit/valve, but there is limited information about risk factors for death or
Autor:
Mary Hunt Martin, Matthew J. Gillespie, John P. Cheatham, Thomas K. Jones, Daniel S. Levi, Jeremy D. Asnes, Robert G. Gray, Allison K. Cabalka, Lisa Bergerson, Lee N. Benson, Daniel Haugan, Doff B. McElhinney
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 2:100979
Autor:
Carl H. Backes, Sharon L. Cheatham, Grace M. Deyo, Scott Leopold, Molly K. Ball, Charles V. Smith, Vidu Garg, Ralf J. Holzer, John P. Cheatham, Darren P. Berman
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundPercutaneous closure of patent ductus arteriosus (PDA) in term neonates is established, but data regarding outcomes in infants born very preterm (
Externí odkaz:
https://doaj.org/article/97ffc44ed5034adda8c16388b489d3e9
Autor:
Evan M. Zahn, Lars Søndergaard, Felix Berger, John P. Cheatham, Andreas Eicken, Julie A. Vincent, Jonathan J. Rome, Jacqueline Kreutzer, Shabana Shahanavaz, Shicheng Weng, Lisa Bergersen, Thomas K. Jones, Doff B. McElhinney, David T. Balzer
Publikováno v:
Shahanavaz, S, Berger, F, Jones, T K, Kreutzer, J, Vincent, J A, Eicken, A, Bergersen, L, Rome, J J, Zahn, E, Søndergaard, L, Cheatham, J P, Weng, S, Balzer, D & McElhinney, D 2020, ' Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve ', JACC: Cardiovascular Interventions, vol. 13, no. 13, pp. 1529-1540 . https://doi.org/10.1016/j.jcin.2020.03.035
Objectives The aim of this analysis was to evaluate outcomes following transcatheter reintervention for degenerated transcatheter pulmonary valves (TPVs). Background TPV replacement (TPVR) with the Melody valve demonstrated sustained relief of right
Autor:
Kevin M, Flanigan, Tatyana A, Vetter, Tabatha R, Simmons, Megan, Iammarino, Emma C, Frair, Federica, Rinaldi, Louis G, Chicoine, Johan, Harris, John P, Cheatham, Sharon L, Cheatham, Brian, Boe, Megan A, Waldrop, Deborah A, Zygmunt, Davin, Packer, Paul T, Martin
Publikováno v:
Molecular therapy. Methodsclinical development. 27
In a phase 1/2, open-label dose escalation trial, we delivered rAAVrh74.MCK.
Autor:
Neil D. Patel, Daniel S. Levi, John P. Cheatham, Shakeel A. Qureshi, Shabana Shahanavaz, Evan M. Zahn
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 1:100452